1014 related articles for article (PubMed ID: 15276472)
1. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
4. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
6. STRESS signaling pathways that modulate cardiac myocyte apoptosis.
Baines CP; Molkentin JD
J Mol Cell Cardiol; 2005 Jan; 38(1):47-62. PubMed ID: 15623421
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
8. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
Muckenfuss H; Hamdorf M; Avots A; Sanzenbacher R; Tschulena U; Cichutek K; Flory E
Mol Immunol; 2006 Mar; 43(8):1172-82. PubMed ID: 16125242
[TBL] [Abstract][Full Text] [Related]
9. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinases and their role in regulation of cellular processes.
Strnisková M; Barancík M; Ravingerová T
Gen Physiol Biophys; 2002 Sep; 21(3):231-55. PubMed ID: 12537349
[TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathways in cardiac myocyte hypertrophy.
Sugden PH
Ann Med; 2001 Dec; 33(9):611-22. PubMed ID: 11817656
[TBL] [Abstract][Full Text] [Related]
15. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.
Diedrichs H; Chi M; Boelck B; Mehlhorn U; Schwinger RH
Eur J Heart Fail; 2004 Jan; 6(1):3-9. PubMed ID: 15012912
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
19. Dual level of interactions between calcineurin and PKC-epsilon in cardiomyocyte stretch.
Vincent F; Duquesnes N; Christov C; Damy T; Samuel JL; Crozatier B
Cardiovasc Res; 2006 Jul; 71(1):97-107. PubMed ID: 16682016
[TBL] [Abstract][Full Text] [Related]
20. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]